OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The self-adjuvant heterocyclic lipid nanoparticles encapsulated with vaccine and STAT3 siRNA boost cancer immunotherapy through DLN-targeted and STING pathway
Zixu Liu, Qingqing Wang, Yupeng Feng, et al.
Chemical Engineering Journal (2023) Vol. 475, pp. 146474-146474
Closed Access | Times Cited: 8
Zixu Liu, Qingqing Wang, Yupeng Feng, et al.
Chemical Engineering Journal (2023) Vol. 475, pp. 146474-146474
Closed Access | Times Cited: 8
Showing 8 citing articles:
Advances in Lipid Nanoparticle‐Based Disease Treatment
Yujie Zhou, Qiqi Ge, Xin Wang, et al.
ChemMedChem (2025)
Closed Access | Times Cited: 1
Yujie Zhou, Qiqi Ge, Xin Wang, et al.
ChemMedChem (2025)
Closed Access | Times Cited: 1
Nano-adjuvant based on lipo-imiquimod self-assembly for enhanced foot-and-mouth disease virus vaccine immune responses via intradermal immunization
Wenzhu Yin, Zeyu Xu, Fang Ma, et al.
Materials Today Bio (2025) Vol. 31, pp. 101567-101567
Open Access
Wenzhu Yin, Zeyu Xu, Fang Ma, et al.
Materials Today Bio (2025) Vol. 31, pp. 101567-101567
Open Access
Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy
Zixu Liu, Boyuan Liu, Yupeng Feng, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15557-15575
Closed Access | Times Cited: 3
Zixu Liu, Boyuan Liu, Yupeng Feng, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15557-15575
Closed Access | Times Cited: 3
Immunomodulatory Nanoparticles Activate Cytotoxic T cells for Enhancement of the Effect of Cancer Immunotherapy
Kory Wells, Tongrui Liu, Lei Zhu, et al.
Nanoscale (2024) Vol. 16, Iss. 38, pp. 17699-17722
Open Access | Times Cited: 3
Kory Wells, Tongrui Liu, Lei Zhu, et al.
Nanoscale (2024) Vol. 16, Iss. 38, pp. 17699-17722
Open Access | Times Cited: 3
Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety
Kangning Wang, Kan Zhou, Nian‐Nian Zhong, et al.
Life Sciences (2024) Vol. 346, pp. 122635-122635
Closed Access | Times Cited: 2
Kangning Wang, Kan Zhou, Nian‐Nian Zhong, et al.
Life Sciences (2024) Vol. 346, pp. 122635-122635
Closed Access | Times Cited: 2
Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform ‘cold’ tumors into ‘hot’ tumors
Xiaohong Ying, Qiaohui Chen, Yongqi Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Xiaohong Ying, Qiaohui Chen, Yongqi Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
A Turbo‐Charging System‐Like Contrast Agent for MRI‐Guided STING Pathway‐Activated Cancer Immunotherapy
Bin Ren, S. Betty Yan, Zongheng Li, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Bin Ren, S. Betty Yan, Zongheng Li, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Application of nanomedicines in tumor immunotherapy
Zirui Gao, Dandan Wan, Min Luo, et al.
Journal of Molecular Cell Biology (2024)
Open Access
Zirui Gao, Dandan Wan, Min Luo, et al.
Journal of Molecular Cell Biology (2024)
Open Access
